Cardinal Health Boosts Annual Profit Outlook on Strong Specialty Medicine Demand
2025-01-14
Reuters on MSN.com
Cardinal Health has raised its annual profit forecast to the higher end of its previous range, driven by robust demand for high-priced specialty medicines and branded pharmaceuticals. This growth is attributed to the company's strong pharmaceuticals unit, which has seen significant uptake of costly yet essential medications. As a result, Cardinal Health is poised to capitalize on the increasing demand for specialty drugs and pharmaceutical services, further solidifying its position in the healthcare industry. With a strong outlook, the company is expected to deliver impressive financial results, making it an attractive prospect for investors. Key drivers include specialty pharmacy services and pharmaceutical distribution.
